Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Clin Immunol. 2009 Oct 29;134(2):206. doi: 10.1016/j.clim.2009.09.010

Figure 2.

Figure 2

Percentage of dendritic cells (DC) in whole blood in SJIA, polyJIA and controls. Data are expressed as percentage of DC in whole blood. A: Total myeloid (CD11c+), including both CD16- and CD16+ DC; SJIA F n=4; SJIA Q n=6; polyJIA n=5; Control n=8. B: Myeloid (CD11c+, CD16-) DC. C: Plasmacytoid (CD123+) DC. F: flare; Q: quiescence. For B and C: SJIA F n=6; SJIA Q n=8; polyJIA n=5; Control n=14. All polyJIA patients are RF- (3 poly F, 2 poly Q). Samples with treatment intensity scores > 2 are in black. Statistical analysis used ANOVA with Bonferroni correction. *: p<0.05; **: p= or <0.01.